This report analyzes three emerging markets, Brazil, Russia and India as targets for HIV drug manufacturers. It discusses the commercial and regulatory environment, guidelines, domestic and multinational competition as well as market entry strategies.
Edit my basket
© Datamonitor 2012. All rights reserved
Terms & Conditions